Evidence map›Paper›PMID 33269415›Full record

ArticleStem cell reviews and reports2021

Protective Effects of Human Liver Stem Cell-Derived Extracellular Vesicles in a Mouse Model of Hepatic Ischemia-Reperfusion Injury.

Alberto Calleri, Dorotea Roggio, Victor Navarro-Tableros, Nicola De Stefano, Chiara Pasquino, Ezio David, Giada Frigatti, Federica Rigo, Federica Antico, Paola Caropreso and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Stem cell reviews and reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Alberto CalleriGeneral Surgery 2U, Liver Transplantation Center, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy.ORCID 0000-0002-4389-9381
Dorotea RoggioGeneral Surgery 2U, Liver Transplantation Center, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy.
Victor Navarro-TablerosScarl. - Molecular Biotechnology Center (MBC), 2i3T - Società per la gestione dell'incubatore di imprese e per il trasferimento tecnologico dell'Università degli Studi di Torino, Turin, Italy.
Nicola De StefanoGeneral Surgery 2U, Liver Transplantation Center, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy.ORCID 0000-0003-0728-5259
Chiara PasquinoDepartment of Medical Sciences, University of Turin, Turin, Italy.
Ezio DavidPathology Unit, Molinette Hospital, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
Giada FrigattiGeneral Surgery 2U, Liver Transplantation Center, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy.
Federica RigoGeneral Surgery 2U, Liver Transplantation Center, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy.
Federica AnticoForb - Fondazione per la Ricerca Biomedica, ONLUS - Molecular Biotechnology Center (MBC), Turin, Italy.
Paola CaropresoClinical Biochemistry Laboratory, Molinette Hospital, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
Damiano PatronoGeneral Surgery 2U, Liver Transplantation Center, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy.
Stefania BrunoDepartment of Medical Sciences, University of Turin, Turin, Italy.
Renato RomagnoliGeneral Surgery 2U, Liver Transplantation Center, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy. renato.romagnoli@unito.it.ORCID 0000-0001-8340-8885
University of Turin · ITFondazione Ricerca Molinette · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITFondazione Europea Ricerca Biomedica · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatic ischemia-reperfusion injury (IRI) is observed in liver transplantation and hepato-biliary surgery and is associated with an inflammatory response. Human liver stem cell-derived extracellular vesicles (HLSC-EV) have been demonstrated to reduce liver damage in different experimental settings by accelerating regeneration and by modulating inflammation. The aim of the present study was to investigate whether HLSC-EV may protect liver from IRI in a mouse experimental model. Segmental IRI was obtained by selective clamping of intrahepatic pedicles for 90 min followed by 6 h of reperfusion. HLSC-EV were administered intravenously at the end of the ischemic period and histopathological and biochemical alterations were evaluated in comparison with controls injected with vehicle alone. Intra liver localization of labeled HLSC-EV was assessed by in in vivo Imaging System (IVIS) and the internalization into hepatocytes was confirmed by fluorescence analyses. As compared to the control group, administration of 3 × 10

Indexed as

Extracellular VesiclesReperfusion InjuryStem CellsAnimalsCytokinesHumansLiverMiceCytokinesAdult stem cellsHepatic inflammationIschemia-reperfusionLiver regenerationMicrovesicles

Identifiers

PMID33269415
PMCPMC8036187
OpenAlexW3108065538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.